Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathways to the best fit of triptans for migraine patients.

Cephalalgia : an international journal of headache - 1 Sept 2008

Buzzi M G

Abstract excerpt

Variability in drug response is a major barrier to the successful treatment of migraine, and most treatments are only optimal in a subset of patients. Although triptans provide the best therapeutic option for the treatment of acute migraine, it has not previously been possible to predict how well patients will respond to a specific triptan or whether they will experience unpleasant adverse events. Hence, it has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotransformation
Share to Clinical Trials as Topic
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Interactions

Share to Meta-Analysis as Topic

Share to Metabolic Networks and Pathways

Share to Migraine Disorders

Share to Serotonin Receptor Agonists

Source

Identifiers

PMID: 18715329
DOI: 10.1111/j.1468-2982.2008.01687.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathways to the best fit of triptans for migraine patients.PMID 18715329Read ↗

Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy.Semantic proximity Read ↗

Molecular mechanisms of migraine: prospects for pharmacogenomics.Semantic proximity Read ↗

Clinical and genetic characterization of non-optimal triptan response among migraine patients.Semantic proximity Read ↗

The impact of genetic factors on the response to migraine therapy.Semantic proximity Read ↗

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine.Semantic proximity Read ↗

Introduction to the Theme "Pharmacological Individuality: New Insights and Strategies for Personalized and Precise Drug Treatment".Semantic proximity Read ↗

An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans.Semantic proximity Read ↗

The influence of genetic constitution on migraine drug responses.Semantic proximity Read ↗

Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine.Semantic proximity Read ↗

Genetics of migraine and pharmacogenomics: some considerations.Semantic proximity Read ↗

Genetic and Phenotypic Profiling of Triptan Users in a Swedish Cluster Headache Cohort.Semantic proximity Read ↗

5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.